Abivax ADR
Abivax ADR (ABVX) Implied Volatility Current
ABVX implied volatility is 85%. IV Rank is —%, placing current premiums in the middle of their 52-week range.
Read more
Tracking ABVX implied volatility helps you identify when options premiums on Abivax ADR are historically cheap or expensive, and where the best trades are hiding. Abivax ADR implied volatility reflects the market's expectation of future price movement: when ABVX IV rises, option premiums increase, creating opportunities for sellers, and when it drops, buyers can find cheaper contracts. Use our scanner to monitor Abivax ADR's implied volatility current levels in real time and filter for high-probability trades.
Implied volatility is derived from option prices using models like Black-Scholes and represents the annualized expected move of an underlying stock. For ABVX, tracking metrics like ABVX IV rank helps traders understand whether current implied volatility is historically high or low. IV rank compares today's reading against the past year's range — a high rank on ABVX signals rich premiums and potential mean-reversion, while a low rank may favor long options strategies.
ABIVAX Société Anonyme discovers and optimizes drugs for the treatment of inflammatory diseases, infectious diseases, and cancer in France. Its principal products include ABX464 that is in Phase IIb clinical trials for the treatment of ulcerative colitis and Crohn's Disease, as well as for COVID-19; Phase IIa clinical trial for the treatment of rheumatoid arthritis diseases; and has completed Phase IIa clinical trial for the treatment of viral remission in patients with HIV. It also develops ABX 196, an immune enhancer candidate that is in Phase 1/2 clinical trials for the treatment of hepatocellular cancer.
In addition, the company engages in the research programs for the treatment of Dengue fever, influenza, and respiratory syncytial virus. ABIVAX Société Anonyme has license contracts with the French National Centre for Scientific Research, the University of Montpellier, and the Institut Curie. The company was incorporated in 2013 and is headquartered in Paris, France.
Premium sellers, directional traders, and spread builders all need the same starting point: a clear read on where ABVX implied volatility sits today versus where it has been. Our scanner ranks Abivax ADR implied volatility against its historical range, surfaces extremes in ABVX IV rank, and pairs every reading with the trades that exploit it. Stop guessing whether Abivax ADR IV is rich or cheap — measure it, then act on it.
Implied Volatility
As of September 16, 2026
Trade options with IV on your side
Track ABVX IV rank across every expiration, spot where volatility is elevated, and identify high-probability setups before the window closes.
Start your 14-day free trial→